Is the protein craze fizzling out? Not if you look at new product launch data, or the fact that producers of both plant and dairy proteins are continuing to add capacity, and consumers are continuing to experiment with new sources, from marine collagen...
The Food and Drug Administration has issued a consumer warning over a line of male sexual enhancement products, citing a number of severe adverse health events suffered by consumers. The alleged marketer of the products has been arraigned on federal charges.
Gut dysbiosis is a common feature of the afflictions that come with aging, according a recent Japanese review. The finding opens wider the door for probiotics and prebiotics in a healthy aging positioning.
The sports nutrition category has undergone significant change in recent years, as many new non-core consumers are seeking out the products. This has coincided with increased regulatory scrutiny and calls for greater transparency, says the COO of ProSupps.
There is a lot of science supporting both the safety and efficacy of probiotics, and the community should do more to talk about this science, says the new director of scientific affairs at the International Probiotics Association.
Pharmako Biotechnologies has had the patent for its LipiSperse technology approved by the World Intellectual Property Organization (WIPO), opening the door for the firm to develop novel formulations for lipid-soluble compounds.
The kratom market has suffered another black eye with the release of a warning letter from FDA citing a marketer for material that was contaminated with salmonella. The letter also illustrates the ongoing regulatory ferment surrounding the botanical.
Two new large-scale and well-conducted clinical trials found that a short course of Lactobacillus rhamnosus GG or L. rhamnosus R0011 plus L. helveticus R0052 did not improve gastroenteritis symptoms in children.